$CTIC News Insider filings one way to track tricky

New Post Public Reply Private Reply Replies (0) Message Board

Mar 6, 2014 at 12:14 PM

$CTIC News

Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com

Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 5:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 4:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 9:47 a.m. Feb. 27, 2014 - Seeking Alpha
Interesting CTIC Put And Call Options For April 19th 11:01 a.m. Feb. 26, 2014 - TheStreet.com
NewLink's Pancreatic Cancer Vaccine and the Feuerstein-Ratain Rule 7:33 a.m. Feb. 26, 2014 - TheStreet.com
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 5:18 p.m. Jan. 31, 2014 - Seeking Alpha
Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
First Week Of CTIC January 2016 Options Trading 1:18 p.m. Jan. 22, 2014 - TheStreet.com
Cell Therapeutics (CTIC) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. Jan. 22, 2014 - TheStreet.com
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013 7:00 a.m. Jan. 21, 2014 - TheStreet.com
Five Worst, Pandering Drug Stocks of J.P. Morgan Healthcare Confab Week 3:52 p.m. Jan. 17, 2014 - TheStreet.com
Cell Therapeutics provides corporate update, share rise 8:25 a.m. Jan. 14, 2014 - Seeking Alpha
Cell Therapeutics Regains Rights to Two In-Development Cancer Medicines 4:47 p.m. Jan. 13, 2014 - Wall St. Cheat Sheet
The J.P. Morgan Healthcare Confab Monday Morning News Dump 9:06 a.m. Jan. 13, 2014 - TheStreet.com
Cell Therapeutics regains rights to cancer compounds from Novartis 8:23 a.m. Jan. 13, 2014 - Seeking Alpha
Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from Novartis 5:01 a.m. Jan. 13, 2014 - benzinga.com
Time to Analyze Small-Caps Again 1:00 p.m. Jan. 10, 2014 - RealMoney.com
Cell Therapeutics Inc. (CTIC) Shares March Higher, Can It Continue? - Tale of the Tape 7:47 a.m. Jan. 7, 2014 - Zacks.com

Cell Therapeutics to Present at the 26th Annual ROTH Conference 1:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 4:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 1:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 1:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 1:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 9:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 10:11 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 1:30 a.m. Feb. 3, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia 1:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Cell Therapeutics Announces GOG Completes Patient Enrollment in GOG-0212 Phase 3 Clinical Trial of Paclitaxel Poliglumex (Opaxio™) as Maintenance Therapy in Ovarian Cancer 1:30 a.m. Jan. 28, 2014 - PR Newswire - PRF
Most Active Stocks Range from Online Game Maker to Biopharmaceuticals: Zynga Inc. (NASDAQ:ZNGA), Dynavax Technologies Corp. (NASDAQ: DVAX), Cell Therapeutics Inc. (NASDAQ:CTIC) 7:22 a.m. Jan. 20, 2014 - ACCESSWIRE
Morning Buzzers: Cell Therapeutics Inc, Stratasys, Galena Biopharma, Cliffs Natural Resources 10:52 a.m. Jan. 14, 2014 - ACCESSWIRE
Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress 1:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds 1:30 a.m. Jan. 13, 2014 - PR Newswire - PRF
Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics 8:00 a.m. Jan. 7, 2014 - PR Newswire
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE 1:30 a.m. Jan. 6, 2014 - PR Newswire
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat 1:30 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 1:30 a.m. Dec. 18, 2013 - PR Newswire
Positive Trend Scan List: Cell Therapeutics Inc, Micron Technology, Tiger Oil and Energy, General Motors, Twitter Inc 9:25 a.m. Dec. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kia's Double Win: Telluride and K4 Grab Buzz Awards

Kia's Major Scoops in the Automotive Scene If you've been hawking the auto industry lately, Kia's latest accolades probably caught your eye. In what seems like a feather in their cap, the 2027 Kia Telluride and the 2026 K4 Hatchback nabbed victories at the Second Annual Buzz Awards. CarBuzz, HotCars, and TopSpeed—the trio of car gurus who know a thing or two about...

First-Time Clermont Homebuyers Face Unexpected Hurdles

Welcome to the Wild Ride of Buying a Home! When folks step into the homebuying ring, especially in places like Clermont, Florida, they often don't realize how chaotic things can get. It's like being thrown into a boxing match without gloves. Brandie Mathison-Klein from the Mathison-Klein Group shines a light on this in a HelloNation piece, spilling the beans on what...

Bybit Expands ByPick Game with Broader Market Reach

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Coastal Financial Faces $470M Wipeout: Investor Alert

Revelations Hit Coastal Financial Hard Alright, pull up a chair and let’s chew over what just happened with Coastal Financial Corporation (NASDAQ: CCB). This is the sort of deal that makes seasoned investors shake their heads in disbelief. Between October 28, 2024, and July 29, 2026, anyone buying into Coastal was buying into a mess they didn’t sign up for. We're...

Xavier Ochsner Opens State-of-the-Art Medical School

A New Era for Medical Education in New Orleans If you're familiar with New Orleans, you know it's a city defined by its vibrancy, culture, and resilience. Well, the Xavier Ochsner College of Medicine is adding to that narrative with the opening of their spanking new Center for Medical Education. It's a project that promises to shake things up in the best possible way for...

Sunbeam 1000hp's Historic Return Ignites Daytona Celebration

The Sunbeam 1000hp: A Roaring Legacy Reborn There's something downright electric about seeing a slice of the past roar back into life. Now, gearheads and history buffs alike have a reason to celebrate: the Sunbeam 1000hp is coming back to the sands of Daytona Beach in 2027. It's been a mighty long 100 years since Sir Henry Segrave tore across those very sands, clocking in...

HitPaw's V6.0.0 Aces AI Image Upscaling and Denoise

New Frontiers with HitPaw's Latest V6.0.0 Innovation keeps on keeping on, doesn't it? HitPaw has rolled out FotorPea V6.0.0, promising a trio of AI-enhanced features that claim to make your images sharper, cleaner, and more naturally rendered than a fresh cup of diner coffee. Any creator worth their salt knows the hassle of dealing with pixelated messes; this update might...

Navigating Funeral Arrangements: A Straightforward Guide

When the reaper comes knocking, families are left juggling grief and logistics—it ain't easy. Jake Leonetti from Lewis Funeral Chapel in Bremerton, Washington, has been in the trenches long enough to know the drill. His insights might just make those funeral arrangements a bit smoother, so let's cut to the chase. First Order of Business: Contact a Funeral Director First...

Lilly's $3.5B Bet: Next-Gen Obesity Drug Site

Pennsylvania Becoming a Pharma Hub There's a big pharma shuffle happening in the heart of Pennsylvania, folks. Eli Lilly's throwing a whopping $3.5 billion into a new facility in Lehigh Valley, marking it the latest pawn in their larger $50 billion strategy to bolster medicine production right here in the U.S. You talk about commitment, and this investment is no small...

Estonian Apartments Fortify Foundations with Penetron

Cementing Long-Term Trust in Tartu Apartments When you're talking about real estate, especially with high groundwater levels, a solid foundation isn't just a metaphor—it's a lifeline. The 18-unit Saekoja 5 project in Tartu, Estonia, recognized this from the get-go, deciding to put PENETRON ADMIX SB through its paces for the elevator pits and foundation slab. Near the...